Compounds > mitomycin
Page last updated: 2024-08-16

mitomycin and olaparib

mitomycin has been researched along with olaparib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auerbach, AD; Kim, Y; Lach, FP; Smogorzewska, A; Spitz, GS; Veturi, U1
Benes, CH; Birkelbach, M; Dahm-Daphi, J; Daly, B; Ebright, MI; Ferraiolo, N; Gheorghiu, L; Kachnic, LA; O'Hara, C; Pfäffle, HN; Sequist, LV; Spencer, C; Whetstine, JR; Willers, H; Zou, L1
Azad, NS; De Jesus-Acosta, A; Donehower, RC; Fine, RL; Goggins, M; Jaffee, EM; Johnson, BA; Laheru, DA; Le, DT; Myzak, MC; Oberstein, PE; Yarchoan, M; Zheng, L1
Gu, S; Jin, L; Ma, J; Ni, X; Pan, Q; Wang, J; Xu, M; Zhen, N; Zhu, J1

Other Studies

4 other study(ies) available for mitomycin and olaparib

ArticleYear
Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4.
    Blood, 2013, Jan-03, Volume: 121, Issue:1

    Topics: Camptothecin; Cell Line; Cross-Linking Reagents; DNA; DNA Mutational Analysis; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Endodeoxyribonucleases; Endonucleases; Fanconi Anemia; Humans; Mitomycin; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Interaction Mapping; Protein Structure, Tertiary; Recombinant Fusion Proteins; Recombinases; Topoisomerase I Inhibitors

2013
Detection of impaired homologous recombination repair in NSCLC cells and tissues.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:3

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA Damage; Fanconi Anemia Complementation Group D2 Protein; Humans; Immunoenzyme Techniques; Lung Neoplasms; Microscopy, Fluorescence; Mitomycin; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Rad51 Recombinase; Recombination, Genetic; Recombinational DNA Repair; Tumor Cells, Cultured; Tumor Stem Cell Assay

2013
Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.
    Oncotarget, 2017, Jul-04, Volume: 8, Issue:27

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cisplatin; Female; Humans; Irinotecan; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pancreatic Neoplasms; Phthalazines; Piperazines; Retreatment; Treatment Outcome

2017
Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage.
    Anti-cancer drugs, 2018, Volume: 29, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carrier Proteins; Cell Growth Processes; Cell Line, Tumor; DNA Damage; Drug Synergism; Endodeoxyribonucleases; Ginsenosides; Hep G2 Cells; Hepatoblastoma; Humans; Hydroxyurea; Liver Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Nuclear Proteins; Phthalazines; Piperazines; Random Allocation; Recombinational DNA Repair; Xenograft Model Antitumor Assays

2018